Tuberkuloz ve Toraks-Tuberculosis and Thorax

Scope & Guideline

Advancing research in respiratory health.

Introduction

Welcome to your portal for understanding Tuberkuloz ve Toraks-Tuberculosis and Thorax, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageMulti-Language
ISSN0494-1373
PublisherTURKISH ASSOC TUBERCULOSIS & THORAX
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTUBERK TORAK / Tuberk. Toraks
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O AKIN KAYA MD, PROFESSOR, DEPT CHEST DISEASES, FAC MEDICINE, ANKARA 06100, Turkiye

Aims and Scopes

The journal 'Tuberkuloz ve Toraks-Tuberculosis and Thorax' focuses on a broad spectrum of respiratory diseases, with a particular emphasis on tuberculosis and related pulmonary conditions. Its aims include advancing knowledge in the field through clinical studies, reviews, and innovative research methodologies.
  1. Tuberculosis Research:
    A core focus of the journal is on tuberculosis, including its diagnosis, treatment, and complications. Studies often explore novel therapeutic approaches and public health strategies to combat TB.
  2. Respiratory Disease Management:
    The journal covers various aspects of managing chronic respiratory diseases such as asthma, COPD, and interstitial lung diseases, emphasizing clinical outcomes and patient management strategies.
  3. Pulmonary Pathophysiology and Diagnostics:
    Research on the underlying pathophysiological mechanisms of respiratory diseases, alongside advances in diagnostic techniques like imaging and biomarkers, is a consistent theme.
  4. COVID-19 Impact and Related Respiratory Conditions:
    Given the recent pandemic, there is a significant focus on the effects of COVID-19 on respiratory health, including long-term sequelae and management strategies.
  5. Innovative Therapeutics and Technologies:
    The journal promotes studies on the latest therapeutic innovations, including biologics and personalized medicine, particularly in the treatment of severe asthma and other chronic conditions.
Recent years have seen the emergence of new themes within the journal, reflecting current trends in respiratory medicine and public health. These topics highlight the evolving landscape of research priorities.
  1. Long COVID and Post-COVID Conditions:
    There is a growing body of literature addressing the long-term effects of COVID-19, including post-COVID syndrome, which is crucial for understanding and managing ongoing respiratory issues.
  2. Telemedicine and Remote Patient Monitoring:
    The shift towards telemedicine, particularly during and after the pandemic, has led to increased research on its effectiveness in managing respiratory diseases and enhancing patient care.
  3. Biologics and Targeted Therapies:
    Research on the use of biologics for severe asthma and other conditions is on the rise, reflecting a trend towards personalized medicine and targeted treatment approaches.
  4. Impact of Environmental Factors on Respiratory Health:
    Emerging studies explore how environmental factors, such as air pollution and climate change, affect respiratory health, indicating a significant shift towards public health and environmental health intersections.
  5. Artificial Intelligence in Pulmonology:
    The application of AI and machine learning in diagnosing and managing respiratory diseases is gaining traction, with studies focusing on its potential to enhance diagnostic accuracy and treatment outcomes.

Declining or Waning

While the journal maintains a diverse range of topics, certain themes have seen a decline in recent publications. These areas may reflect shifting research priorities or reduced interest in specific methodologies or conditions.
  1. Traditional Epidemiological Studies:
    There appears to be a decline in traditional epidemiological studies focused solely on the prevalence of respiratory diseases, as newer methodologies and technologies gain traction.
  2. Basic Science Research on Respiratory Diseases:
    Research that emphasizes basic science or laboratory studies without direct clinical application has become less prominent, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Niche Respiratory Conditions:
    Coverage of less common respiratory conditions, such as rare lung diseases, has diminished in favor of more prevalent conditions and those with greater public health impact.

Similar Journals

Jornal Brasileiro de Pneumologia

Elevating pulmonary medicine with open-access insights.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Exploring the frontiers of pulmonary medicine and patient care.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Lung India

Elevating standards in lung disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

RESPIRATORY MEDICINE

Transforming Knowledge into Clinical Practice
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

THORAX

Exploring the frontiers of respiratory medicine.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Minerva Respiratory Medicine

Connecting research and practice in pulmonary health.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

RESPIRATORY RESEARCH

Pioneering Insights for a Breath of Fresh Air
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

Multidisciplinary Respiratory Medicine

Unlocking the potential of respiratory research for global impact.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Annals of the American Thoracic Society

Pioneering the path in pulmonary and respiratory advancements.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Egyptian Journal of Chest Diseases and Tuberculosis

Exploring breakthroughs in chest diseases and tuberculosis management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.